Skadden advised WeRide Inc., while Latham & Watkins advised the underwriters on the transaction. WeRide was officially listed on the Nasdaq Global Select Market under the...
WeRide’s Nasdaq Listing
KLA Corporation’s $750 Million Senior Notes Offering
Latham & Watkins represented KLA Corporation in the offering, and Cravath, Swaine & Moore represented the underwriters. KLA Corporation (Nasdaq: KLAC) announced it closed a public offering...
Skyward Specialty’s Secondary Offering of Common Stock
DLA Piper advised Skyward Specialty, and Latham advised the underwriters. Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) closed on June 12, 2023 its underwritten offering of...
Sterling Check Corp’s Secondary Public Offering
Latham & Watkins advises the underwriters Goldman Sachs & Co. and J.P. Morgan Securities, on Sterling Check Corp.’s secondary public offering. Sterling Check Corp., a leading...
Extra Space Storage’s Acquisition of Life Storage
Latham & Watkins advised Extra Space Storage on the deal, and Morrison Foerster advised Citigroup Global Markets Inc. Extra Space Storage Inc. (NYSE: EXR) and Life...
QuantaSing’s $40 Million IPO
Wilson Sonsini represented QuantaSing, while Latham & Watkins advised the joint bookrunners on the offering. QuantaSing Group Limited announced the pricing of its initial public offering...
Skyward Specialty’s $134 Million Upsized Initial Public Offering
DLA Piper advised Skyward Specialty, while Latham & Watkins LLP represented the underwriters in the offering. Skyward Specialty Insurance Group, Inc., a specialty insurance company, delivering...
Bionano Genomics’ Acquisition of Purigen Biosystems
Latham & Watkins LLP represented Purigen in the transaction. Bionano Genomics, Inc. (NASDAQ: BNGO) has entered into a definitive agreement to acquire Purigen Biosystems, Inc., a...
Extra Space Storage’s $590 Million Acquisition of Storage Express
Latham & Watkins represented Extra Space in the transaction. Extra Space Storage Inc. and its subsidiaries (collectively Extra Space or the Company) (NYSE: EXR) has completed...
Alignment Healthcare’ $250 Million Debt Financing
Latham & Watkins represented Alignment Healthcare in the transaction. Alignment Healthcare, Inc.(Alignment Healthcare) (NASDAQ: ALHC), a leading tech-enabled MedicareAdvantage company, has announced the close of an...
Pfizer’s $25 Million Equity Investment in Zentalis Pharmaceuticals
Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological...
Extra Space’s $400 Million Senior Notes Offering
Latham & Watkins represented Extra Space in the offering. Extra Space Storage Inc., a leading owner and operator of self-storage facilities in the United States and a...